Bio Bharati Life Science Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 15 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 M
as on 10-12-2024
- Revenue -27.07%
(FY 2023)
- Profit -6636.40%
(FY 2023)
- Ebitda -168.98%
(FY 2023)
- Net Worth -16.29%
(FY 2023)
- Total Assets -12.58%
(FY 2023)
About Bio Bharati Life Science
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 M.
Alpana Ghosh, Arun Patra, and Malini Sen serve as directors at the Company.
- CIN/LLPIN
U24233WB2009PTC132434
- Company No.
132434
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Feb 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Bio Bharati Life Science Private Limited offer?
Bio Bharati Life Science Private Limited offers a wide range of products and services, including Laboratory Chemicals, Textile, Dyeing & Finishing Chemical, Textile Enzymes, Pathology Lab Equipments, DNA Ladder, Rapid Test Kit, DNA Extraction Kit, Reference Books & Study Material, Teaching Charts, Teaching Aid.
Who are the key members and board of directors at Bio Bharati Life Science?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Alpana Ghosh | Director | 20-Feb-2009 | Current |
Arun Patra | Director | 20-Jun-2011 | Current |
Malini Sen | Director | 04-Jan-2023 | Current |
Financial Performance of Bio Bharati Life Science.
Bio Bharati Life Science Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27.07% decrease. The company also saw a substantial fall in profitability, with a 6636.4% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bio Bharati Life Science?
Unlock access to Bio Bharati Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Indian Overseas Bank Creation Date: 17 Mar 2010 | ₹3.00 M | Open |
How Many Employees Work at Bio Bharati Life Science?
Unlock and access historical data on people associated with Bio Bharati Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio Bharati Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio Bharati Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.